DEVICE EXPORT REFORM MEASURE PASSES HOUSE OCT. 26 AS PART OF BUDGET BILL; SENATE BILL LACKS EXPORT LANGUAGE, INVESTIGATIONAL DEVICE COVERAGE PROVISION
This article was originally published in The Gray Sheet
Legislation allowing device and drug manufacturers to export unapproved products to World Trade Organization member countries without FDA clearance passed the House as part of the budget reconciliation bill approved Oct. 26 by a 227-203 vote.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.